about
Inhalation delivery of proteins from ethanol suspensionsLow viscosity highly concentrated injectable nonaqueous suspensions of lysozyme microparticles.Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies.In situ forming biodegradable poly(ε-caprolactone) microsphere systems: a challenge for transarterial embolization therapy. In vitro and preliminary ex vivo studies.Preclinical toxicology and pharmacology of dimethylacetamide, with clinical notes.Extended hildebrand solubility approach: satranidazole in mixtures of dioxane and water.Solubility Prediction of Satranidazole in Aqueous N,N-dimethylformamide Mixtures Using Extended Hildebrand Solubility Approach.Low-energy nanoemulsification to design veterinary controlled drug delivery devices.Antinociceptive effects of herkinorin, a MOP receptor agonist derived from salvinorin A in the formalin test in rats: new concepts in mu opioid receptor pharmacology: from a symposium on new concepts in mu-opioid pharmacology.Processing of nimesulide-PEG 400-PG-PVP solid dispersions: preparation, characterization, and in vitro dissolution.The effects of pH and mixed solvent systems on the solubility of oxytetracycline.
P2860
Q28398029-ECBB93DF-0B07-41DF-9569-59EC932D5F4AQ34581175-DC075D46-248D-44E0-97A1-42F333F499EDQ36909351-876A9673-10A2-4F84-B97D-8D3ECE5DE803Q38918467-B500F4A2-CDE1-4FFD-95C2-1C509F10951EQ39564005-F0E8F81B-E4B0-49A9-A662-FB546A493D6AQ42005490-5F466F1F-E823-49F1-BD1C-18849AF31086Q42154768-01D344E9-54D4-459D-8BD7-AD8F761F27E5Q42398265-DC8F4E85-9810-448E-93AE-543E3D397CD9Q42633341-CA20B262-344A-4623-9537-5F008AD233A6Q44437230-F04C0AB8-A1E2-4418-98C5-301D64D18101Q44866142-3753C401-8F5C-464F-9D4F-F64B7C560199
P2860
description
1963 nî lūn-bûn
@nan
1963 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1963 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1963年の論文
@ja
1963年論文
@yue
1963年論文
@zh-hant
1963年論文
@zh-hk
1963年論文
@zh-mo
1963年論文
@zh-tw
1963年论文
@wuu
name
USE OF NONAQUEOUS SOLVENTS IN PARENTERAL PRODUCTS.
@ast
USE OF NONAQUEOUS SOLVENTS IN PARENTERAL PRODUCTS.
@en
type
label
USE OF NONAQUEOUS SOLVENTS IN PARENTERAL PRODUCTS.
@ast
USE OF NONAQUEOUS SOLVENTS IN PARENTERAL PRODUCTS.
@en
prefLabel
USE OF NONAQUEOUS SOLVENTS IN PARENTERAL PRODUCTS.
@ast
USE OF NONAQUEOUS SOLVENTS IN PARENTERAL PRODUCTS.
@en
P356
P1476
USE OF NONAQUEOUS SOLVENTS IN PARENTERAL PRODUCTS.
@en
P2093
NOSEWORTHY MM
SPIEGEL AJ
P304
P356
10.1002/JPS.2600521003
P407
P577
1963-10-01T00:00:00Z